AcelRx pain drug shows mixed results in mid-stage trial

by admin on April 24, 2013

(Reuters) – AcelRx Pharmaceuticals Inc said a mid-stage trial of its experimental pain drug showed that a higher dose of the therapy met the main goal of reducing acute pain in patients, but the lower dose failed to meet the goal. Results from the trial showed that patients receiving 30 mcg doses of the drug, administered not more than once per hour, had significantly greater pain reduction – as …

View full post on pain – Yahoo! News Search Results

Previous post:

Next post: